In addition, downstream targets of the wnt/β-catenin signaling pathway responsible for HCC proliferation and metastasis, such as c-Myc and leucine-rich repeat-containing G (LGR5), respectively, may be considered as potential targets for therapy (84). The gene discussed is MYC; the disease is hepatocellular carcinoma.